REG - Greggs PLC - Directorate Change

GreggsAnnouncement

04/04/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240404:nRSD2346Ja&default-theme=true

RNS Number : 2346J  Greggs PLC  04 April 2024

 

4 April 2024

 

GREGGS plc

 

Appointment of Non-Executive Director

The Board of Greggs plc is pleased to announce that it has appointed Tamara
Rogers as an independent non-executive director with effect from 1(st) June
2024. The Board intends that on appointment Tamara will join the Audit,
Remuneration and Nominations Committees.

Tamara is currently the Chief Marketing Officer of Haleon plc, the FTSE100
listed world-leading consumer healthcare company, and has over 30 years'
experience across a range of commercial and marketing roles. Tamara joined GSK
in 2018 having spent almost 25 years with Unilever plc, where she held
significant leadership positions, and was appointed as CMO at Haleon ahead of
its demerger from GSK and listing in 2022.

Matt Davies, Chair of Greggs, said "We are delighted to announce Tamara's
appointment to our Board. She brings a wealth of experience across marketing,
customer insight, and digital commerce which will be of significant value as
Greggs continues its journey as a multi-channel consumer business."

 

Listing Rule 9.6.13R (1) to (6) Disclosure

There are no further matters required by paragraphs 9.6.13R (1) to (6) of the
Listing Rules to be disclosed in relation to Tamara Rogers.

ENDS

 ENQUIRIES:

 Greggs plc                                Hudson Sandler
 Roisin Currie, Chief Executive            Wendy Baker / Hattie Dreyfus /

 Richard Hutton, Chief Financial Officer   Nick Moore
 Tel:  0191 281 7721                       Tel:  020 7796 4133

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOAUPUMACUPCGMW